BARNES ALANE P (Senior VP, Chief Legal Officer) sold 5.2% of their position (21.77K shares) of BIOCRYST PHARMACEUTICALS INC on the open market
Open‑market sale worth $166.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/23/2025ACC: 0000882796-25-000043
Officer· Senior VP, Chief Legal Officer
Since Nov 2018
-38.67K
Net shares
Net seller
$291.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
38.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−16.90K
Price / share
$7.41
Trade value
$125.24K
% of position
3.9%
12/19/2025
437.43K→420.52K
Common Stock
Direct
Shares
−21.77K
Price / share
$7.65
Trade value
$166.56K
% of position
5.2%
12/22/2025
420.52K→398.75K
Total
Net shares
−38.67K
Net value
-$291.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | F · Tax Withholding | −16.90K | $7.41 | $125.24K | 3.9% | 437.43K | 420.52K |
| Common Stock Direct | 12/22/2025 | S · Sale | −21.77K | $7.65 | $166.56K | 5.2% | 420.52K | 398.75K |
| Total | −38.67K | -$291.81K | ||||||
Derivative Transactions0
No derivative transactions reported